Results 151 to 160 of about 13,059 (186)
Characteristics of Adult Severe Uncontrolled Asthma Patients in Primary Care and Modifications in Prescribed Inhalation Treatments. [PDF]
Konradsen JR +5 more
europepmc +1 more source
The precision bronchodilator therapy in airflow limitation with asthma defining reversibility: An appraisal through pharmaco-responsiveness-based real-world observation. [PDF]
Bhattacharyya P, Sen S, Ghosh S, Kar A.
europepmc +1 more source
Recurrent COVID-19 infection and the risk of exacerbation, mortality and long covid in patients with chronic obstructive pulmonary disease: a nationwide retrospective cohort study. [PDF]
Lee HW +6 more
europepmc +1 more source
Clinical impact of disease stability on exacerbation and mortality in COPD: a retrospective cohort study. [PDF]
Kim SH, Lee JK, Min KH, Kim DK, Lee HW.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Jangan Seperti Jaring Laba-Laba
2021Istilah sarang laba-laba dalam konteks hukum, berasal dari Honore de Balzac. “Hukum seperti sarang laba-laba, menangkap serangga-serangga kecil dan membiarkan yang besar-besar lolos”. Tentu pernyataan empiris ini tidak mungkin semua orang setuju. Buku ini mengajak kita untuk jangan berhenti berpikir agar hukum tidak seperti yang digambarkan Balzac ...
exaly +2 more sources
KABINET TV GEOMETRIK MOTIF LABA-LABA
SULUH: Jurnal Seni Desain Budaya, 2022Tujuan perancangan desain adalah mengaplikasikan unsur dekoratif jaring laba-laba pada produk kabinet TV. Metode yang digunakan adalah penelitian kualitatif dengan teknik pengumpulan data menggunakan cara studi literatur, observasi dan wawancara secara langsung seperti tempat usaha, showroom mebel, gambar katalog, majalah, internet, dan perpustakaan.
Aldi Hasan Kholiq +2 more
openaire +1 more source
▼Olodaterol—another LABA for COPD
Drug and Therapeutics Bulletin, 2015▼Olodaterol solution for inhalation (Striverdi Respimat—Boehringer Ingelheim) is a long-acting beta2 agonist (LABA) licensed for once-daily use as maintenance bronchodilator therapy for chronic obstructive pulmonary disease (COPD). This is the third LABA to be licensed in the UK for once-daily use for patients with COPD. DTB has previously reviewed the
openaire +2 more sources

